Dogwood Therapeutics, Inc. (DWTX)
DWTX Stock Price Chart
Explore Dogwood Therapeutics, Inc. interactive price chart. Choose custom timeframes to analyze DWTX price movements and trends.
DWTX Company Profile
Discover essential business fundamentals and corporate details for Dogwood Therapeutics, Inc. (DWTX) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
17 Dec 2020
Employees
8.00
Website
https://www.dwtx.comCEO
Gregory Duncan
Description
Dogwood Therapeutics, Inc. is an emerging biotechnology firm dedicated to creating innovative antiviral treatments. Their primary goal is to address illnesses that stem from atypical immune reactions provoked by viral infections. Its leading therapeutic candidate, IMC-1, is a precise fixed-dose combination of famciclovir and celecoxib, engineered to combat fibromyalgia. Additionally, the company is advancing IMC-2, which blends valacyclovir and celecoxib, aiming to alleviate the array of symptoms linked to long COVID, including persistent fatigue, sleep disturbances, cognitive issues, pain, autonomic dysfunction, and anxiety. Previously operating as Virios Therapeutics, Inc., the organization adopted the name Dogwood Therapeutics, Inc. in October 2024. Established in 2012, the company maintains its main office in Alpharetta, Georgia.
DWTX Financial Timeline
Browse a chronological timeline of Dogwood Therapeutics, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 12 Aug 2026
EPS estimate is -$0.13.
Earnings released on 14 May 2026
EPS came in at -$0.15 surpassing the estimated -$0.22 by +31.82%.
Earnings released on 18 Mar 2026
EPS came in at -$0.26 surpassing the estimated -$0.86 by +69.77%.
Earnings released on 6 Nov 2025
EPS came in at -$8.20 falling short of the estimated -$1.23 by -566.67%.
Earnings released on 13 Aug 2025
EPS came in at -$1.99 falling short of the estimated -$1.26 by -57.94%.
Earnings released on 8 May 2025
EPS came in at -$4.21 falling short of the estimated -$0.77 by -446.75%.
Earnings released on 26 Feb 2025
EPS came in at -$5.90 falling short of the estimated -$1.36 by -333.60%.
Earnings released on 7 Nov 2024
EPS came in at -$2.05 falling short of the estimated -$1.18 by -73.73%.
Earnings released on 8 Aug 2024
EPS came in at -$0.05 surpassing the estimated -$0.07 by +28.57%.
Earnings released on 9 May 2024
EPS came in at -$0.07 surpassing the estimated -$0.08 by +12.50%.
Earnings released on 31 Dec 2023
EPS came in at -$1.43 surpassing the estimated -$1.75 by +18.17%.
Earnings released on 30 Sept 2023
EPS came in at -$1.62 surpassing the estimated -$2.25 by +28.13%.
Earnings released on 30 Jun 2023
EPS came in at -$1.96 falling short of the estimated -$1.25 by -56.52%.
Earnings released on 31 Mar 2023
EPS came in at -$2.07 surpassing the estimated -$4.00 by +48.28%.
Earnings released on 31 Dec 2022
EPS came in at -$2.79 .
Earnings released on 30 Sept 2022
EPS came in at -$7.00 surpassing the estimated -$11.50 by +39.14%.
Earnings released on 30 Jun 2022
EPS came in at -$11.01 .
Earnings released on 31 Mar 2022
EPS came in at -$11.89 .
Earnings released on 31 Dec 2021
EPS came in at -$13.54 .
Earnings released on 30 Sept 2021
EPS came in at -$12.33 .
DWTX Stock Performance
Access detailed DWTX performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
